Abstract
Objective
To estimate inter-session coefficient of repeatability (CR) of visual function and OCTA metrics over 3 months in diabetic macular ischaemia (DMI) in stable laser-treated proliferative diabetic retinopathy (PDR) patients.
Methods
This prospective study recruited patients with stable PDR for at least 6 months following pan-retinal photocoagulation with visual acuity of at least 54 ETDRS letters. DMI was confirmed on OCTA as FAZ area of at least 0.5 mm2 or parafoveal capillary dropout in at least one quadrant if the FAZ area was less than 0.5 mm2. Repeatability was assessed at baseline and 3 months by calculating the coefficients of repeatability (CR) and intraclass correlation coefficient (ICC). The Bland Altman (BA) plots including 95% CI bands for the bias (mean difference) and upper and lower limits of agreement (LOA) were used to visualise the agreement of the measurements.
Results
88 eligible eyes of 63 participants were included in the analysis. The CR for best corrected visual acuity (BCVA) was 10.1 ETDRS letters (95% CI 8.5–11.7 ETDRS letters), and for low luminance visual acuity (LLVA) was 12.4 letters (95% CI 10.4–14.4). The ICC for BCVA and LLVA was 0.81 and 0.75 respectively. For Square Root of Foveal Avascular Zone (SQRT-FAZ) area, CR and ICC was 0.043 mm and 1.00 respectively. The Bland-Altman plots suggest that the level of agreement is wider for vascular density (VD) metrics compared to FAZ parameters.
Conclusion
We recommend using the FAZ metrics for quantitative measurements of DMI outcomes due to the excellent repeatability of manually corrected FAZ area.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 18 print issues and online access
269,00 € per year
only 14,94 € per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout



Similar content being viewed by others

Data availability
The data that support the findings of this study are not openly available due to reasons of sensitivity and are available from the corresponding author upon reasonable request
References
EDTRS. Classification of Diabetic Retinopathy from Fluorescein Angiograms: ETDRS Report Number 11. Ophthalmology. 1991;98:807–22.
Bresnick GH, Condit R, Syrjala S, Palta M, Groo A, Korth K. Abnormalities of the Foveal Avascular Zone in Diabetic Retinopathy. Arch Ophthalmol. 1984;102:1286–93.
Mansour AM, Schachat A, Bodiford G, Haymond R. Foveal avascular zone in diabetes mellitus. Retina. 1993;13:125–8.
Mendis KR, Balaratnasingam C, Yu P, Barry CJ, McAllister IL, Cringle SJ, et al. Correlation of Histologic and Clinical Images to Determine the Diagnostic Value of Fluorescein Angiography for Studying Retinal Capillary Detail. Invest Ophthalmol Vis Sci. 2010;51:5864–9.
Spaide RF, Klancnik JM, Cooney MJ. Retinal Vascular Layers in Macular Telangiectasia Type 2 Imaged by Optical Coherence Tomographic Angiography. JAMA Ophthalmol. 2015;133:66–73.
Gorrand JM. Diffusion of the human retina and quality of the optics of the eye on the fovea and the peripheral retina. Vis Res. 1979;19:907–12.
Dunbar HMP, Behning C, Abdirahman A, Higgins BE, Binns AM, Terheyden JH, et al. MACUSTAR Consortium. Repeatability and Discriminatory Power of Chart-Based Visual Function Tests in Individuals with Age-Related Macular Degeneration: A MACUSTAR Study Report. JAMA Ophthalmol. 2022;140:780–9.
Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1991;98:766–85.
Sivaprasad S, Prevost AT, Vasconcelos JC, Riddell A, Murphy C, Kelly J, et al. Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial. Lancet. 2017;389:2193–203.
Gross JG, Glassman AR, Jampol LM, Inusah S, Aiello LP, Antoszyk AN, et al. Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial. JAMA. 2015;314:2137–46.
Fawzi AA, Fayed AE, Linsenmeier RA, Gao J, Yu F. Improved Macular Capillary Flow on Optical Coherence Tomography Angiography After Panretinal Photocoagulation for Proliferative Diabetic Retinopathy. Am J Ophthalmol. 2019;206:217–27.
Fenner BJ, Tan GSW, Tan ACS, Yeo IYS, Wong TY, Cheung GCM. Identification of imaging features that determine quality and repeatability of retinal capillary plexus density measurements in OCT angiography. Br J Ophthalmol. 2018;102:509–14.
Garrity ST, Iafe NA, Phasukkijwatana N, Chen X, Sarraf D. Quantitative Analysis of Three Distinct Retinal Capillary Plexuses in Healthy Eyes Using Optical Coherence Tomography Angiography. Investig Ophthalmol Vis Sci. 2017;58:5548–55.
Camino A, Zhang M, Gao SS, Hwang TS, Sharma U, Wilson DJ, et al. Evaluation of artifact reduction in optical coherence tomography angiography with real-time tracking and motion correction technology. Biomed Opt Express. 2016;7:3905–15.
Ghasemi Falavarjani K, Habibi A, Anvari P, Ghasemizadeh S, Ashraf Khorasani M. Shenazandi, Het al.Effect of segmentation error correction on optical coherence tomography angiography measurements in healthy subjects and diabetic macular oedema. Br J Ophthalmol. 2020;104:162–6.
Karatsai E, Sen P, Gurudas S, Sivaprasad S. Low Luminance Visual Acuity and Low Luminance Deficit in Proliferative Diabetic Retinopathy. J Clin Med 2021;10:358.
Yao X, Alam MN, Le D, Toslak D. Quantitative optical coherence tomography angiography: A review. Exp Biol Med. 2020;245:301–12.
Munk MR, Kashani AH, Tadayoni R, Korobelnik JF, Wolf S, Pichi F, et al. Standardization of OCT Angiography Nomenclature in Retinal Vascular Diseases: First Survey Results. Ophthalmol Retin. 2021;5:981–90.
Bland JM, Altman DG. Measurement error. BMJ. 1996;313:744 https://doi.org/10.1136/bmj.313.7059.744. Sep 21PMID: 8819450; PMCID: PMC2352101.
Bland JM (2004): What is the standard error of the within-subject standard deviation. [serial online, cited 5 September 2008. http://wwwusers.york.ac.uk/~mb55/meas/seofsw.htm
Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307–10.
Koo TK, Li MY. A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. J Chiropr Med. 2016;15:155–63.
Yehoshua Z, Wang F, Rosenfeld PJ, Penha FM, Feuer WJ, Gregori G. Natural History of Drusen Morphology in Age-Related Macular Degeneration Using Spectral Domain Optical Coherence Tomography. Ophthalmology. 2011;118:2434–41.
Guo J, She X, Liu X, Sun X. Repeatability and Reproducibility of Foveal Avascular Zone Area Measurements Using AngioPlex Spectral Domain Optical Coherence Tomography Angiography in Healthy Subjects. Ophthalmologica. 2017;237:21–8.
Wijesingha N, Tsai WS, Keskin AM, Holmes C, Kazantzis D, Chandak S, et al. Optical Coherence Tomography Angiography as a Diagnostic Tool for Diabetic Retinopathy. Diagnostics (Basel). 2024;14:326.
Szpernal J, Gaffney M, Linderman RE, Langlo CS, Hemsworth K, Walesa A, et al. Assessing the Sensitivity of OCT-A Retinal Vasculature Metrics. Transl Vis Sci Technol. 2023;12:2.
Akrobetu DY, Robbins CB, Ma JP, Soundararajan S, Quist MS, Stinnett SS, et al. Intrasession Repeatability of OCT Angiography Parameters in Neurodegenerative Disease. Ophthalmol. Sci. 2023;3:100275.
Lee YM, Lee MW, Song YY, Baek SK, Lee YH. Repeatability of Optical Coherence Tomography Angiography Measurements in Patients with Retinal Vein Occlusion. Korean J. Ophthalmol. 2021;35:159–67.
Cocce KJ, Stinnett SS, Luhmann UFO, Vajzovic L, Horne A, Schuman SG, et al. Visual Function Metrics in Early and Intermediate Dry Age-related Macular Degeneration for Use as Clinical Trial Endpoints. Am J Ophthalmol. 2018;189:127–38.
Puell MC, Barrio AR, Palomo-Alvarez C, Gomez-Sanz FJ, Clement-Corral A, Perez-Carrasco MJ. Impaired mesopic visual acuity in eyes with early age-related macular degeneration. Invest Ophthalmol Vis Sci. 2012;53:7310–4.
Lujan BJ, Calhoun CT, Glassman AR, Googe JM, Jampol LM, Melia M, et al. DRCR Retina Network. Optical Coherence Tomography Angiography Quality Across Three Multicenter Clinical Studies of Diabetic Retinopathy. Transl Vis Sci Technol. 2021;10:2.
Linderman RE, Muthiah MN, Omoba SB, Litts K, Tarima S, Visotcky A, et al. Variability of Foveal Avascular Zone Metrics Derived From Optical Coherence Tomography Angiography Images. Transl Vis Sci Technol. 2018;7:20.
Funding
The investigator-initiated study was funded by Boehringer Ingelheim International GmbH (Grant number: SIVS1048). This study was also supported by the NIHR Biomedical Research Centre and Clinical Research Facility at the Moorfields Eye Hospital National Health Service Foundation Trust and the University College London Institute of Ophthalmology.
Author information
Authors and Affiliations
Contributions
Conceptualization: S.T. and S.S.; Data curation: S.T, and W-S.T.; Formal analysis: S.G.; Funding acquisition: S.S.; Methodology: S.T, S.G. and S.S; Project administration: S.S.; Resources: S.T., W-S.T. and S.S.; Supervision: T.Y, G.C, E.P, S.S; Visualization: S.G. and S.T.; Writing – original draft: S.T, S.G. and S.S.; Writing - review & editing: S.S. Review and approval of final manuscript: S.T., W-S.T., S.G., G.C., T.Y., E.P., S.S,
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests. Sridevi Thottarath and Wei-Shan Tsai has received travel support from Boehringer Ingelheim. Dr. Sivaprasad reported receiving financial support from AbbVie, Amgen, Apellis, Bayer, Biogen, Boehringer Ingelheim, Novartis, Eyebiotech, Eyepoint Pharmaceuticals, Janssen Pharmaceuticals, Nova Nordisk, Optos, Ocular Therapeutix, Kriya Therapeutics, OcuTerra, Roche, Stealth Biotherapeutics and Sanofi. Sobha Sivaprasad is the Editor-in-Chief of EYE. Dr Cheung is a consultant for Topcon, Novartis, Bayer, Allergan, Roche, Boehringher-Ingelheim, and Samsung. Dr Cheung is a member of the editorial board of EYE. Taffeta Ching Ning Yamaguchi is an employee of Boehringer-Ingelheim.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Thottarath, S., Tsai, WS., Gurudas, S. et al. Intersession repeatability of visual function and OCTA metrics in eyes with diabetic macular ischaemia. Eye 39, 906–912 (2025). https://doi.org/10.1038/s41433-024-03505-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41433-024-03505-3